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1. Introduction 
 
 
1.1. Cartilage types, composition and function 
 
 
Cartilage is a specialized tissue characterized by the presence of extracellular 
matrix enriched with glycosaminoglycans and proteoglycans. These substances are 
bound to collagen and elastic fibres. The different ratio between the components of 
extracellular matrix results in different properties of three types of cartilage, i.e.  
hyaline cartilage, elastic cartilage and fibrocartilage.  
Hyaline cartilage is the most common type of cartilage in human body. In a 
moving joint, an articular cartilage absorbs forces, and enables smooth movement of 
the joint. Hyaline physeal cartilage is necessary for the growth of bones during the 
postnatal period (Junqueira et al. 1999).  
Compared to hyaline cartilage, elastic cartilage contains not only type II 
collagen fibres but also a dense net of elastic fibres which is responsible for the high 
elasticity of the elastic cartilage. It is present in auricles, external auditory meatus 
walls, Eustachian tube, epiglottis, and cuneiform cartilage. 
Fibrocartilage forms a transition from fibrous tissue to cartilage. It is 
characterized by a dense net of type I collagen fibres, which are parallel to applied 
forces, and a low amount of amorphous ECM. Chondrocytes are usually organized in 
columns. The fibrocartilage present in intervertebral discs and ligament insertions is 
able to withstand a high mechanical load.  
 
 
1.1.1. Articular cartilage 
 
 
An adult articular cartilage contains only 1 % (V/V) of specialized cells, 
chondrocytes. Chondrocytes surrounded by pericellular matrix rich in 
glycosaminoglycans form chondrons, which are surrounded by a basophilic capsule 
in the middle and deep zone (Lee and Loeser 1998, Ross et al. 2006), and create an 
avascular and alymphatic tissue with no innervation. Chondrocytes from different 
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zones have different size, shape and metabolic activity but all contain organelles 
necessary for matrix synthesis, including endoplasmic reticulum, and Golgi 
membranes (Fig.1). In some chondrocytes, short cilia protrude from the cell to the 
extracellular matrix. They may play a role in the perception of mechanical changes in 
the matrix (Buckwalter and Mankin 1998a). Chondrocytes usually do not form cell-
to-cell contact as they are surrounded by extracellular matrix. In addition, 
variabilities of cell number, chondrocyte surface area, and matrix volume per 
chondrocyte were observed in different locations in the joint. However, a uniform 
volume per chondron was found (Quinn et al. 2005).   
 
                               
Fig. 1. Histology of native articular cartilage of rabbit. Hematoxilin-eosin 
staining, magn. × 80. 
  
 All components of extracellular matrix are synthesized by chondrocytes. 
After their synthesis, these components must be organized into a highly ordered 
framework. Interestingly, chondrocytes are metabolically active but their low density 
in the cartilage results in a low metabolic activity of the tissue. To maintain the 
proper structure of cartilage as a response to mechanical loading of the joint, the 
cartilage requires continuous replacement of degraded matrix components. In 
skeletally mature cartilage, the volume of tissue does not substantially change but the 
articular surface can be remodeled (Buckwalter and Mankin 1998a).  
In adult cartilage, nutrition of the chondrocytes is provided by a synovial 
fluid. Diffusion of the synovial fluid through the cartilage is restricted not only by its 
thickness but also by the charges and specific molecular configuration (Buckwalter 
and Mankin 1998a). 
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The major components of the extracellular matrix of hyaline cartilage are type 
II collagen (≈ 60 % of the dry weight), hyaluronic acid, PGs (≈ 25 %), and other 
proteins and glycoproteins (≈ 15 %) (Buckwalter and Mankin 1998a). In addition to 
these components, elastic cartilage contains elastin that allows its excellent elasticity. 
On the other hand, the dense net of type I collagen permits the fibrocartilage to 
withstand high mechanical loading in intervertebral discs and ligament insertions 
(Junqueira et al. 1999).  
Water contributes to 80 % of the wet weight of articular cartilage. It contains 
gases, small proteins, metabolites, and high concentrations of cations that balance the 
negatively charged PGs. The majority of water interacts with structural 
macromolecules, particularly the large PGs; this helps to maintain water in the 
matrix. 
Articular cartilage is organized in four zones: superficial, transitional, deep, 
and calcified. The structural macromolecules include collagens, PGs and non-
collagenous proteins. The superficial zone contains the highest density of 
chondrocytes in comparison with deeper zones (Quinn et al. 2005). It is rich in 
collagen; however, in a deep zone, all matrix components are uniformly distributed. 
Dense matrix of collagen fibrils lies in parallel to the joint surface that gives this 
zone a greater tensile stiffness and strength, so that they can resist shear stress 
generated during movement of the joint. The tight mesh of type II, IX and XI 
collagens throughout the tissue provides the cartilage the tensile stiffness and 
strength, and contributes to the cohesiveness of the tissue by entrapping the large 
PGs. The tensile strength depends on intermolecular cross-linking. The role of type 
IX and XI collagens is probably to form and stabilize the primary collagen fibrils 
assembled from type II collagen and to connect the meshwork with PGs (Eyre et al. 
1992, Buckwalter and Mankin 1998a). Type VI collagen is concentrated 
pericellularly; it is rich in RGD sequences and may help chondrocytes to attach to the 
matrix. Type X, present only in the calcified zone, probably plays a role in the 
mineralization of cartilage (Eyre et al. 1992, Buckwalter and Mankin 1998a). 
PGs consist of a protein core and one or more glycosaminoglycans. 
Glycosaminoglycans include HA, chondroitin sulfate, keratan sulfate and dermatan 
sulfate. The concentration of glycosaminoglycans is variable within an articular 
cartilage and also varies with age, injury or disease, e.g. osteoarthritis (Wang et al. 
2006).  
9 
The highly viscous nature of synovial fluid is important for normal joint fluid. 
Highly viscous lubricating fluid consists of lubricin and hyaluronic acid (Simon 
1999). Hyaluronan is a high-molar-mass linear glycosaminoglycan consisting of a 
repeating disaccharide unit N-acetylglucosamine, and D-glucuronic acid. HA 
synthesis is linked with the expression of several hormones (e.g. insulin, 
prostaglandins, interleukin, and somatomedins) and most growth factors (e.g. 
platelet-derived growth factor, epidermal growth factor, bFGF, and transforming 
growth factor) as well. Conversely, inhibition of HA in mesenchymal or epithelial 
cells arrested mitosis in vitro even in the presence of growth factors (King et al. 
1991). 
HA plays an important role in many physiological and pathological 
processes, such as cell proliferation, cell recognition, cell migration, cell 
differentiation, and inflammation. Most of these responses are mediated through HA-
CD 44 interaction (Miyake et al. 1990, Laurent and Fraser 1992). Exogenous HA is 
able to enhance wound healing. The mechanism is still unknown; however, HA is 
probably a part of feedback that promotes cell proliferation and migration in actively 
growing tissues. Moreover, the role of HA in both water homeostasis and an increase 
of tissue hydration can positively influence wound healing (King et al. 1991, 
Maniwa et al. 2001). In hamsters, hyaluronic acid, administered topically into the 
defect, accelerated the wound healing which was connected with a higher 
microcirculatory perfusion at the site of repair (King et al. 1991). In osteoarthritic 
patients, both the concentration and the molar mass of intraarticular endogenous HA 
were decreased (Wang et al. 2006).   
 
 
1.1.2. Physeal cartilage 
 
 
Longitudinal growth of long bones occurs by endochondral ossification. In 
tubular bones, primary and secondary centers of growth give rise to physes. The 
primary centers of ossification give rise to proximal and distal metaphyseal physes 
(Fig.2), (Byers and Brown 2006). The secondary center of ossification expands 
within epiphysis in all directions; in one direction it comes to underlie the articular 
cartilage, the articular cartilage physis, in another direction it backs on metaphyseal 
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physis where it forms a complex with epiphyseal and diaphyseal side. The epiphyseal 
side ossifies early, while the metaphyseal side remains active till puberty (Byers and 
Brown 2006, Andrade et al. 2007).  
The primary and secondary centers develop similarly; chondrocytes are 
organized in four zones with different proliferation rate, differentiation rate, and cell 
morphology. The resting zone, adjacent to epiphysis, contains spherical chondrocytes 
which are distributed single or in pairs, and their proliferation activity is low. They 
are considered as “stem-like cells” capable of generating new clones of proliferative 
chondrocytes. In the proliferative zone, chondrocytes are flattened, organized into 
isogenic rows parallel to the long axis of the bone. The highest proliferation rate is 
observed in this zone. Columnar arrangement of larger chondrocytes which do not 
proliferate is typical of the hypertrophic zone. In addition, changes of matrix 
 
 
 
Fig. 2. The nomenclature employed to specify physeal sites. 
 According to Byers and Brown (2006). 
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composition including type X collagen synthesis are present. A hypertrophic 
cartilage in the degenerative zone is invaded by blood vessels and bone cells from 
adjacent metaphysis, and a newly formed cartilage is remodeled into a bone (Byers 
and Brown 2006, Andrade et al. 2007). 
During bone growth, chondrocytes within the growth plate undergo distinct 
proliferative and differentiation phases. In the proliferative phase, new cells are 
introduced into the growth plate and matrix synthesis takes place. In the 
differentiated phase (the hypertrophic phase) the chondrocytes alter the surrounding 
matrix in anticipation of calcification and vascularization. At the metaphyseal 
junction, the differentiated chondrocytes undergo apoptosis and osteoblasts infiltrate 
the matrix scaffold to complete the ossification process (Olney et al. 2004). 
Endochondral bone formation at the growth plate is regulated by a complex 
of endocrine network involving growth hormone, IGF-I, thyroid hormone, 
glucocorticoid, and sex steroids. Moreover, a set of autocrine and paracrine factors 
that regulate chondrocyte proliferation, differentiation, and ossification, is involved 
in this process (Andrade et al. 2007). 
 
 
1.1.3. Influence of motion and loading on cartilage 
 
 
During physiological loading, the cartilage is subjected to hydrostatic 
pressure in a range from 5 to 15 MPa (Carver and Heath 1999, Darling and 
Athanasiou 2003). The mechanical stimuli may influence both chemical composition 
and the structure of the new cartilaginous tissue, and are essential for the nutrition of 
chondrocytes.  
Furukawa et al. reported that weight-bearing cartilage of repaired rabbit 
femoral condyle cartilage exhibits a significantly higher degree of glycosylation of 
collagens in comparison with non-weight-bearing cartilage (Furukawa et al. 1980). 
Helminen et al. reported that immobilization of the knee of young dogs for 11 weeks 
caused a decrease of the PG content in the cartilage to 38 %, and showed softer 
cartilage with decreased shear modulus. Partial restoration of the PG content was 
observed when dogs where subsequently allowed to move freely for 15 weeks. 
Nonstrenuous running of dogs (4 km/day) showed higher thickness of non-calcified 
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cartilage and increased both PG synthesis and shear modulus. On the other hand, 
strenuous running (20 and 40 km/day) decreased the PG content in lateral femoral 
condyle, the thickness of lateral condyle cartilage, and the shear modulus (Helminen 
et al. 1992).  
 
 
1.2. Osteoarthritis 
 
 
Osteoarthritis (OA), which is also described as osteoarthrosis, degenerative 
joint disease, degenerative OA or hypertrophic OA, is characterized by retrogressive 
changes in both cells and matrix that result in the loss of both structure and function 
of the articular cartilage. According to the extent of degenerative changes, three 
stages of OA have been described.  
The first stage of OA includes a disruption of the macromolecular framework 
of the matrix, a decreased aggregation of PGs, a lower concentration of aggrecan, 
and a lower length of glycosaminoglycan chains. At the same time, increased water 
content, altered collagenous organization, and induced collagen degradation lead into 
swelling of aggrecan molecules, increase of permeability of the tissue, and reduced 
cartilage stiffness. PGs of the osteoarthritic joint contained different chondroitin 
sulfate chains (Caterson et al. 1992, Bank et al. 2000). In another study on 
osteoarthritic articular cartilage, the authors observerd decreased aggrecan expression 
(Eid et al. 2006). 
During the second stage of OA, the following changes stimulate a cellular 
response: tissue damage, changes in osmolarity, density, strain, and release of 
mediators. The cellular response includes both synthesis and degradation of the 
matrix, and induced chondrocyte proliferation. This in turn can lead to restoration of 
the tissue, maintaining the tissue in an altered state, or increase the volume of 
cartilage; these changes can persist for years.  
Failure to stabilize or restore the tissue leads to the third stage of OA which 
includes a progressive loss of cartilage as well as a decline in the chondrogenic 
anabolic and proliferative response. It can result from both a mechanical damage of 
chondrocytes and a down-regulation of chondrocytic response to anabolic cytokines. 
The loss of cartilage is accompanied by both remodeling and sclerosis of the 
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subchondral bone, and the formation of both bone cysts and marginal osteophytes. 
Bone remodeling that is combined with the loss of cartilage changes the shape of the 
joint, and may lead to shortening of the involved limb deformity and instability 
(Buckwalter and Mankin 1998b). Clinical symptoms include pain, a restriction of 
motion, crepitus with motion, joint effusion, and deformity of the joint. OA occurs 
most frequently in foot, knee, hip, spine, and hand joints.  
OA most frequently develops in the absence of a known cause (primary OA), 
or as a result of joint injury, infection, or hereditary, developmental, metabolic or 
neurological disorders (secondary OA). The prevalence of primary OA increases 
from 5 % of people younger than twenty-five years to 80 % of people more than 
seventy-five years old (Buckwalter and Mankin 1998b). This is going to be an 
economical problem.   
 
 
1.3. Therapy of osteoarthritis 
 
 
1.3.1. Non-invasive cartilage regeneration and hyaluronan supplementation 
 
 
Cartilage lesions are often treated in a conservative manner (Towheed 2002). 
NSAIDs are often used in the therapy of OA but they do not affect the cause of 
osteoarthritis. Moreover, people who might have a significant improvement from the 
anti-inflammatory and analgesic effects of these drugs are also those who are at the 
greatest risk of developing potentially serious NSAID-induced gastrointestinal side 
effects. The new generation of cyclooxygenase-selective inhibitors includes 
rofecoxib, and valdecoxib, which effectively relieve pain in OA, but are known for 
potentially severe cutaneous, and cardiovascular adverse reactions, respectively 
(Moskowitz et al. 2006). More recently, various substances have proved their 
chondroprotective effect in the treatment of OA. They include chondroitin sulfate, D-
glucosamine sulfate, and hyaluronic acid. After a long-term supplementation of 
glucosamine sulfate, a significant reduction of symptoms as well as positive 
radiological changes were observed in patients with OA (Reginster et al. 2001, 
Pavelka et al. 2002).  
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Intraarticular supplementation of HA with molar-mass average from 1 × 106 
to 7 × 107 Da is often used in the therapy of symptomatic OA of patients who do not 
respond to nonpharmacological treatment and analgesic drugs (Adam and Ghosh 
2001). Viscosupplementation with high-molar-mass HA used in the therapy of 
patients with OA of both the knee (Wobig et al. 1999) and the ankle (Sun et al. 2006) 
significantly relieved the patient`s pain. This effect increased with higher molar-mass 
hyaluronan viscosity (Wobig et al. 1999). Recently, the down-regulation of OA- 
associated enzyme aggrecanase-2, OA-associated genes TNF-α, IL-8, and inducible 
nitric oxid synthase were observed in synoviocytes by the high molar-mass HA 
(Wang et al. 2006). 
 
 
1.3.2. Standard surgical therapy of osteoarthritis 
 
 
Isolated chondral or osteochondral defects may result from traumas that leave 
most of the articular surface intact. They mostly occur in young patients and can 
cause joint pain, effusion, and mechanical dysfunction. When they are left untreated, 
they fail to heal. Moreover, large defects can progress to a symptomatic degeneration 
of the joint. Therefore, treatment of selected isolated defects can prevent or delay the 
development of OA. 
Standard surgical techniques, such as debridement, penetration of 
subchondral bone, osteotomy, joint distraction, transplantation of autographs from 
non-weight-bearing zone into a defect, and soft tissue grafts, such as perichondrial, 
periosteal flap, joint capsule, or fascia have the potential to stimulate the formation of 
new articular surface, and may decrease symptoms and improve joint function 
(Niedermann et al. 1985, Hoikka et al. 1990, Buckwalter and Lohmander 1994, 
Outerbridge et al. 1995, Buckwalter and Mankin 1998b). However, they are not able 
to restore the articular cartilage (Buckwalter and Lohmander 1994, Levy et al. 1996, 
Buckwalter and Mankin 1998b).  
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1.3.2.1. Penetration of subchondral bone 
 
 
The penetration of subchondral bone is a method developed to stimulate the 
formation of a new articular surface. In regions with a full-thickness loss or an 
advanced degeneration of articular cartilage, penetration of the exposed subchondral 
bone disrupts subchondral blood vessels and leads to the formation of fibrin clot over 
the bone surface. If the surface is protected from excessive loading, undifferentiated 
mesenchymal cells migrate into the clot, proliferate, and differentiate into cells with 
morphological features of chondrocytes. In some instances they form 
fibrocartilaginous tissue, but in others no repair was observed (Shapiro et al. 1993, 
Buckwalter and Lohmander 1994).  
Surgeons developed various methods for the penetration of subchondral bone, 
including a debridement of degenerated articular cartilage, drilling into subchondral 
bone through arthrotomy, arthroscopic abrasion of articular surface, and creation of 
multiple small-diameter defects or fractures, referred to as a microfracture. 
Unfortunately, the bone marrow stimulation techniques are less successful in patients 
older than 40 years (Buckwalter and Lohmander 1994, Levy et al. 1996, Steadman et 
al. 1997, Minas 2001, Dorotka et al. 2005a).  
Compared to drilling, microfracture is reported to produce less heat and thus, 
less necrosis, and to maintain the integrity of the subchondral bone. Failure of the 
microfracture treatment was observed in patients with chronic lesions, advancing 
age, preoperative space narrowing, isolated chondral defects, or no continuous 
passive motion after surgery. Rehabilitation after surgery is considered as an 
important factor of cartilage regeneration (Steadman et al. 1997). 
 
 
1.3.2.2. Soft-tissue grafts 
 
 
The treatment of osteoarthritic joints with soft-tissue grafts most often 
involves debridement of the joint and interposition of soft-tissue grafts consisting of 
fascia, joint capsule, muscle, tendon, periosteum, or perichondrium between the 
debrided or resected articular surface (Niedermann et al. 1985, O'Driscoll et al. 1988, 
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Hoikka et al. 1990). Periosteal graft implantation was able to regenerate hyaline-like 
tissue in the osteochondral defects in rabbits in a long-term experiment (Rubak 
1982).  In another experiment Rubak et al.(1982) showed that cartilage tissue in the 
defect originated from the periosteal graft and not from the subchondral bone. 
Periosteal graft implantation was successful in patients younger than 35 years 
(Niedermann et al. 1985), or 50 years (Hoikka et al. 1990), but failed in the treatment 
of  a 55-year-old man with a severe patellar arthrosis (Hoikka et al. 1990).     
 
 
1.3.3. Autologous chondrocyte transplantation 
 
 
One of the modern techniques involves autologous chondrocytes injected into 
the defect that is covered by periosteal flap sealed with a fibrin glue (Brittberg et al. 
1994, Breinan et al. 1997, 2001). This teqnique is based on a combination of two 
chondrogenic factors: cambium cells of the periosteum and suspension of 
chondrocytes. However, in animal models, the positive effect of ACI was observed 
only three months after the implantation (Breinan et al. 2001), but no effect was 
observed after 12 and 18 months (Breinan et al. 1997). That may be ascribed to the 
lack of retention of the cells in the defect due to a possible displacement of the 
periosteal flap, uneven distribution of cells, dedifferentiation of chondrocytes, and 
the location of the defect. Erggelet et al. (2003) decribed the arthroscopic ACI 
technique for a treatment of osteochondral defects. In clinical practice, the ACI 
technique has been successfully performed on patients aged 14 to 58 years since 
1987 (Brittberg et al. 1994, Minas 2001, Marlovits et al. 2006). 
Although ACI demonstrated an improved function and a diminished pain, 
several complications, such as periosteal hyperthrophy, delamination of the 
transplant, arthrofibrosis and transplant failure have also occurred (Minas 2001, 
Marlovits et al. 2006). Higher improvement was observed in patients with lower 
severity of the defects (Minas 2001). 
The second generation of ACI technique (or ACT) involves the injection of 
autologous chondrocytes under a three-dimensional biodegradable scaffold, such as 
a collagen bilayer membrane (Chondro-GideTM membrane, Geistlich Biomaterials) 
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(Marlovits et al. 2006). The advantage of this technique in comparison with ACT is 
no hypertrophy.   
 
 
1.3.4. Matrix-associated autologous chondrocyte implantation 
 
 
The third generation of ACT is based on autologous chondrocyte-seeded 
biomaterials, such as cell carriers (matrix-associated autologous chondrocyte 
transplantation). The biomaterials are used as three-dimensional constructs; they 
secure cells in the defect area, and enhance their proliferation and differentiation. 
After debridement, the biomaterials seeded with cells are trimmed to match the size 
of the defect and implanted into the defect without the use of the periosteal flap. 
Fibrin is often used to fix the scaffold (Trattnig et al. 2005). 
The fleece of hyaluronan derivative (Hyalograft C) (Pavesio et al. 2003, 
Trattnig et al. 2006), type I/III collagen membrane (Verigen, Genzyme; Igor, André), 
bilayer membrane consisting of  type I/III and II collagen (Dorotka et al. 2005b), and 
polylactin and polyglactin (BioTissue, Germany) were intensively studied in clinical 
(Cherubino et al. 2003, Pavesio et al. 2003, Marlovits et al. 2005, Trattnig et al. 
2005, Marlovits et al. 2006), and animal studies (Willers et al. 2005, Dorotka et al. 
2005a, Dorotka et al. 2005b). Dorotka reported improved a healing of chondral 
defects in sheep and a formation of hyaline cartilage compared to microfracture 
treatment or microfracture with unseeded collagen matrix implantation. 
In comparison with the second generation of ACT, this technique allows 
chondrocytes to redifferentiate and to produce their own extracellular matrix. 
Subjective and objective improvement has been observed in 76 % to 100 % of 
patients. These results suggest that MACI is the appopriate technique for treatment of 
chondral/osteochondral defects, and can be used in combination with other 
techniques, such as microfracture. MACI can be used for the therapy of larger 
defects with satisfactory results.  
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1.4. Physeal fractures and their therapy 
 
 
In children, physeal fractures belong to serious bone injuries. Mann and 
Rajmaira reported that 30 % of 2,650 long-bone fractures in children involved a 
physeal growth plate (Mann and Rajmaira 1990). Traumas of proximal growth plate 
of humerus, distal physes of tibia, fibula, humerus and femur represent 2−10 % of all 
bone injuries (Ashcraft et al. 2005). Limb long-bones injuries, except for humerus, 
are often accompanied by a damage of physis, which leads to a bony bridge 
formation at the site of physeal injury. According to the extent and localization of the 
physeal defect, the affected limb may become shorter, may display angular 
deformity, or both. Although 25−35 % of the physeal fractures in humans lead to 
some shortening or an angular deformity, only about 10 % of the fractures resulted in 
functional problems  (Mizuta et al. 1987, Mann and Rajmaira 1990).  
Many experimental and clinical attempts for surgical correction of bone 
deformities have been described, only varying degrees of success have been 
achieved. They include stapling, epiphyseodesis, osteotomy, excision of bony bridge 
and insertion of interpositioning materials such as bone cement, fat, or polymeric 
silicone (Lee et al. 1993). Chondrocytes, perichondrial cells, or MSCs used either 
alone or embedded in a three-dimensional scaffold have shown the potential to repair 
physeal defects in animal models, and they represent a promising approach to the 
treatment of physeal defects. The aim of a novel therapeutical approach is to prevent 
a bony bridge formation and thus to avoid the further problems with both a 
shortening and a deformation of the limb (Park et al. 1994, Lee et al. 1998, Ahn et 
al. 2004, Yoo, W. J. et al. 2005).  
 
 
1.5. Cell culture  
 
  
Autologous chondrocytes are widely used in clinical practice. They are well 
characterized and their proliferation and differentiation is known to be tailored by 
modifying both the culture medium composition and the cultivation systems, such as 
two- or three-dimensional sytems, or dynamic cultivation. However, some problems 
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concerning harvesting of sufficient amount of healthy cartilage led to using 
mesenchymal stem cells in tissue engineering of cartilage.  
 
 
1.5.1. Chondrocyte culture and differentiation  
 
 
Cartilage contains only 1 % (V/V) of chondrocytes. To obtain an adequate 
number of chondrocytes for subsequent therapy of osteochondral or chondral defects, 
they have to be enzymically digested from the piece of non-weight-bearing cartilage 
and then multiplied in vitro into a few millions in a few weeks (Lee and Loeser 
1998). 
The two-dimensional culture of chondrocytes allows their multiplication, but 
causes chondrocyte dedifferentiation into fibroblast-like cells after a few passages as 
well (Fig.3). The dedifferentiation of chondrocytes is gradual and is accompanied by 
the decrease of type II collagen synthesis and increase of type I collagen synthesis. 
Moreover, distinct differences were found in chondrocytes obtained from the 
superficial zone and the growth zone; the latter exhibited 20-fold higher type II 
collagen expression than the superficial layer (Darling and Athanasiou 2005). 
However, this dedifferentiation process can be reduced using culture media 
containing growth factors and a low concentration of fetal bovine serum, or serum 
free media (Mandl et al. 2002).  
 
   
 
 
 
 
 
 
Fig. 3. Dedifferentiated fibroblast-like chondrocytes cultured on the tissue culture 
polystyrene for 7 days (left) compared with round redifferentiated chondrocytes 
embedded in fibrin scaffold (right). 
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Addition of TGF-β1 or TGF-β2 into the serum-free medium supplemented 
with insulin-containing supplement ITS+ or IGF-I induce a dose-dependent 
redifferentiation of chondrogenic markers. However, neither insulin nor TGF-β alone 
can induce chondrocyte redifferentiation (Yaeger et al. 1997).  
FBS is often used in cell culture for a stimulation of cell adhesion and 
proliferation but its variable composition causes variability of results. The inhibitory 
or activating effect of FBS on cell proliferation depends on both its amount in a 
culture medium and the time (Vivien et al. 1990, Olney et al. 2004). Human articular 
chondrocytes suspended in alginate gel were able to re-express their chondrogenic 
phenotype if they were cultured in a medium supplemented with specific lots of FBS. 
Other lots of FBS were not efficient, but if they were used in the presence of IGF-I 
and ascorbate, increased mRNA synthesis of both aggrecan and type II collagen was 
observed (Yaeger et al. 1997).   
Various schemes optimizing chondrocyte proliferation and redifferentiation 
have been published that used different combinations of growth factors and other 
additives, and their time-dependent supplementation. In addition, a combination of 
monolayer culture followed by three-dimensional culture was more efficient than the 
two-dimensional system alone (de Haart et al. 1999, Kuriwaka et al. 2003, Miot et 
al. 2006).    
The use of growth factors in the cartilage defect repair needs proper 
understanding of the role of various growth factors in cartilage metabolism and 
knowledge of their potential side effects on cells and tissues in a joint. Moreover, it is 
reported that the effects of growth factors on chondrocytes from osteoarthritic or 
inflamed cartilage are different; for example, osteoarthritic chondrocytes do not 
respond to treatment by IGF-I, which is a homeostatic factor regulating matrix 
synthesis and degradation. Enhanced proteoglycan synthesis in osteoarthritic 
cartilage is caused by the higher sensitivity of the tissue to TGF-β (van den Berg et 
al. 2001). 
 
Chondrocyte culture in three-dimensional scaffolds   
Benya and Shaffer (1982) were the first to describe the ability of 
chondrocytes cultivated in a monolayer to re-express their differentiated phenotype 
in agarose gel. Chondrocytes, cultivated in a monolayer from the third to the sixth 
passages, were embedded in an agarose gel. Consequently, the protein and collagen 
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synthesis by chondrocytes increased to levels higher than those in a monolayer. The 
chondrocytes in the third passage rapidly increased the synthesis of both collagen 
and proteoglycan but chondrocytes from higher passages showed a transient decrease 
before the protein and collagen synthesis increased. Re-expression of proteoglycan 
synthesis was less sensitive to the passage number. The third passage monolayer 
culture of chondrocytes expressed dedifferentiated phenotype for a shorter time, and 
this was probably essential for the redifferentation process.  
The encapsulation of chondrocytes into alginate beads increased type II 
collagen expression but full redifferentiation was not achieved even after two weeks 
(Darling and Athanasiou 2005). The chondroitin sulfate synthesis by freshly isolated 
chondrocytes embedded in Atellocollagen gel was higher than that in a monolayer 
culture. Ultrastructural evaluation revealed than collagen network was organized 
even after one week in a three-dimensional Atelocollagen gel. After three weeks of 
cultivation, the collagen network was well organized with interconnecting collagen 
fibers and more resembled normal cartilage structure (Kuriwaka et al. 2003).  
Similar reddiferentiation of dedifferentiated chondrocytes was observed in 
many types of three-dimensional scaffolds including hydrogels, porous scaffolds, and 
textile scaffolds (Fig.3). Chondrocyte differentiation and cartilaginous matrix 
formation in non-woven PGA mesh was influenced by a sequential supplementation 
of growth factors in the presence of 10 % FBS. A ten-day supplementation with both 
TGF-β1 and FGF-2 followed by an eighteen-day supplementation with IGF-I yielded 
the highest and the best differentiated construct (Pei et al. 2002). 
 
 
Chondrocyte growth plate culture 
The growth hormone is considered to play a key role in the regulation of 
longitudinal bone growth The stimulatory effect of the growth hormone on cell 
proliferation of chondrocytes and other cells is known. It is probably mediated by 
circulating levels of IGF-I or by stimulation of local synthesis and secretion of IGF-I, 
which subsequently induces chondrocyte proliferation through a paracrine or 
autocrine mechanism (Rosselot et al. 1994). The other growth factors, including 
TGF-β, IGF-I and FGFs, may also be involved in autocrine or paracrine control of 
cartilage growth and differentiation. This theory can be supported by the fact that 
they are produced by chondrocytes and are present in growth plate tissue, and they 
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are able to induce chondrocyte proliferation and differentiation (Rosselot et al. 
1994).   
In contrast with mammalian chondrocytes, the proliferation of avian growth 
plate chondrocytes under serum-free conditions seems not to be affected by the 
growth hormone but bFGF displays mitogenic activity that can be enhanced by TGF-
β1 or TGF-β1 + IGF-I. IGF-I was found to be a key factor for matrix synthesis which 
can be enhanced by adding TGF-β1, TGF-β1 + bFGF, or serum (Rosselot et al. 
1994).   
 
 
1.5.2. Mesenchymal stem cells 
 
  
1.5.2.1. Mesenchymal stem cell culture  
 
 
The characteristics of stem cells are their self-renewal and their ability to 
differentiate into one or more specialized cell types. Traditionally, stem cells can be 
divided into two major groups: embryonic stem cells and tissue-specific stem cells. 
Embryonic stem cells can differentiate into all cell types and can be maintained 
indefinitely in vitro without loss of their differentiation potential. However, they are 
still used only in experimental studies because of ethical and legal problems 
concerning the use of human embryos.  
Many adult tissues contain stem cell populations that have a capacity for 
tissue renewal after trauma, disease or aging. Multipotential MSCs are precursor 
cells localized in the stromal compartment of bone marrow (Pittenger et al. 1999). 
They are of interest for tissue engineering because of their easy multiplication and 
multilineage potential (Huang et al. 2005). They are able to differentiate into tissues 
of mesenchymal lineages including cartilage, bone, fat, tendon, muscle, neuronal 
tissue and stroma; they can also differentiate into cardiomyocytes and hepatocytes. 
Their number inversely correlates with age and depends on the site of extraction and 
systemic disease state. Besides bone marrow, MSCs are present in blood, synovial 
membrane, periosteum, adipose tissue, trabecular bone, dermis, cartilage, and 
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muscle. MSCs from these sources have a more limited differentiation potential (Tuan 
et al. 2003, Alsalameh et al. 2004).  
MSCs from bone marrow are isolated using Percoll gradient centrifugation, 
and adherent cells are multiplied in vitro. When cultured long-term in vitro, they 
remain in a stable undifferentiated state. They are characterized by a set of markers 
on their surface including SH2, SH3, CD29 (integrin β1), CD44, CD90, CD106 
(VCAM-1), CD120a, CD124, etc. In contrast, MSCs are negative for other markers 
of hematopoietic lineage such as lipopolysaccharide receptor CD14, CD34, and the 
leukocyte common antigen CD45. After long-term cultivation, MSCs exhibit finite 
life spans (Pittenger et al. 1999) A fraction of isolated human stromal MSCs, 
characterized by negative CD34, CD117 (c-kit), and CD140α markers, exhibited 
a chondrogenic potential (Imabayashi et al. 2003). In the same study, CD29, CD44, 
CD90, CD105, and CD106 were detected in both dedifferentiated chondrocytes and 
stromal MSCs.  
 
 
1.5.2.2. Mesenchymal stem cell differentiation 
 
 
MSC differentiation in vitro is strongly influenced by culture conditions 
including cell density, cell adhesion and growth factors (Tuan et al. 2003). Cartilage 
differentiation is induced by TGF-β superfamily of proteins, such as TGF-β, BMPs, 
other growth factors including bFGF, IGF-1, and other substances, such as 
dexamethasone, ascorbic acid, and hyaluronic acid, but without the presence of fetal 
bovine serum. TGF-β1 seems to play the pivotal role in chondrogenic differentiation 
of MSC cultures from various species. The potential effect of TGF- β is mediated by 
MAP kinases through the cell-cell adhesion molecule N-cadherin, a requisite cell-cell 
interaction in developmental chondrogenesis, which was previously shown to 
mediate embryonic mesenchymal condensation (Johnstone et al. 1998, Ringe et al. 
2002a, Imabayashi et al. 2003, Tuan et al. 2003, Indrawattana et al. 2004). However, 
TGF-β1 alone was not able to induce complete chondrogenic differentiation in 
human MSC but a combination of  TGF-β1 either with BMP-6 or IGF-1 enhanced 
their chondrogenic potential accompanied by increased synthesis of aggrecan and 
type II collagen (Indrawattana et al. 2004).   
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In addition, Wnt and Wnt-related family of signaling proteins are involved in 
adult cartilage homeostasis. Wnt-1-inducible signaling pathway protein 3 (WISP-3) 
is expressed in adult human synoviocytes and articular cartilage, and other Wnts, 
such as Wnt-11, are expressed in developing cartilage and are upregulated during 
MSC chondrogenesis. This suggests the involvement of Wnt signalization in 
chondrogenic differentiation. Interestringly, a higher expression of Wnt-5 by 
synoviocytes in rheumatoid arthritis was observed. Both TGF-β and  Wnt signaling 
are probably mediated via MAP kinases (Tuan et al. 2003, Hegewald et al. 2004). 
In the tissue, the differentiation of MSC is influenced by environmental 
factors, such as oxygen tension. For example, high oxygen tension supports 
osteogenesis, whereas in areas with low oxygen tension chondrogenesis is favored 
(Boyan et al. 1996).  
Moreover, a high-density culture of MSCs, such as in pellets or 
chondrospheres, strongly promotes cartilaginous tissue formation accompanied with 
glycosaminoglycans and type II collagen synthesis even after 10 days; this synthesis 
persisted for 3 months (Pittenger et al. 1999). This system allows cell-cell 
interactions analogous to those that occur in precartilage condensation during 
embryonic development. In comparison to pellet culture, chondrosphere culture did 
not require a scaffold for chondrogenesis, and is sufficient for chondrogenesis of 
dedifferentiated chondrocytes and stromal MSCs (Imabayashi et al. 2003). The best 
chondrogenic differentiation was obtained in the pellet culture with TGF-β and 
dexamethasone (Johnstone et al. 1998). Ringe et al. (2002a) reported type II 
synthesis after 20 days of culture. However, in MSC culture from rabbit postnatal 
bone marrow, chondrogenic differentiation was accompanied by alkaline 
phosphatase activity and type X collagen expression; they indicate that cells 
differentiated into their terminal phenotype, the hypertrophic chondrocytes 
(Johnstone et al. 1998). The more recent study introduced new approaches to MSC 
culture including cycling induction of chondrogenesis by growth factors 
(Indrawattana et al. 2004). 
Osteoarthritic cartilage contains an increased number of CD105+/CD166+ 
positive MSCs, which may result from proliferation of resident progenitor cells or 
from recruitment from other sites; they may be involved in the pathogenesis of 
arthrosis (Alsalameh et al. 2004). In arthritic joints, the inflammatory mediators, 
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such as IL-1 or tumor necrosis factor, may lead to abnormal differentiation of the 
progenitor cells and subsequently to fibrocartilage formation. 
The treatment of large defects in osteoatrhritic patients may be negatively 
influenced by the decreased ability of MSCs to undergo chondrogenic differentiation 
(Murphy et al. 2002). However, this problem has been solved and chondrogenic 
differentiation in pellets was increased, when MSCs were cultured in the presence of 
bFGF in a monolayer culture (Akaogi et al. 2004).    
  
Mesenchymal stem cell culture in three-dimensional scaffolds  
 Two major strategies that use MSCs in tissue engineering are appplied: (1) 
using MSCs for protein delivery by inserting genes coding for a secreted protein and 
implanting the cells into the defect (Lee et al. 2001), or (2) using MSCs as 
multipotential cells (Ringe et al. 2002a, 2002b) In this case the differentiation is 
controlled by a specific differentiation medium and the scaffold environment;  e.g. 
hydroxyapatite ceramics which enhances osteogenic differentiation of MSCs 
compared to tissue-culture polystyrene (Kotobuki et al. 2005). The expression of 
cartilage-specific genes for aggrecan, type II collagen, and Sox-9 mRNA is enhanced 
when they are embedded in PLA-alginate (Caterson et al. 2001) or type II collagen 
scaffold, and reduced when they are embedded in type I collagen (Chen et al. 2005). 
MSCs isolated from bone marrow and periosteum were embedded in a type I 
collagen gel and implanted into the osteochondral defect. After 24 weeks, both cell-
seeded scaffolds were able to repair osteochondral bone and cartilage, but with low 
mechanical properties of the articular cartilage (Wakitani et al. 1994). Similarly, in 
a clinical study, MSC-seeded type I collagen showed only partially repaired articular 
cartilage (Wakitani et al. 2002). Ahn et al. (2004) reported that MSC-seeded onto 
gelatin scaffolds and implanted into physeal defects prevented bony bridge formation 
with varus deformity, the effect was higher in the presence of the TGF-β.  
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1.5.3. Dynamic cultivation of cells 
 
  
 Cyclic mechanical loading is important for chondrocyte function in native 
cartilage. Recently, dynamic cell cultivation has been developed to improve cell 
culture and production of ECM matrix by cells in three-dimensional scaffolds. 
Bioreactor utilizing a dynamic laminar flow (Vunjak-Novakovic et al. 1999), 
intermittent pressure and perfusion significantly stimulated both the collagen and 
GAG synthesis by chondrocytes (Carver and Heath 1999), or GAG synthesis alone 
(Lu et al. 2005). Consequently, the scaffolds showed better mechanical properties. In 
contrast,  in a wavy-walled bioreactor or spinner flask, the shear stress applied to 
chondrocytes caused  increased synthesis of  type I collagen, and the fibroblast-like 
morphology of chondrocytes at the scaffold perifery (Vunjak-Novakovic et al. 1999, 
Bueno et al. 2005).  
 
 
1.6. Scaffold formulation  
 
 
The scaffolds used in tissue engineering must be biocompatible and 
nonimmunogenic. Bioresorbable materials allow controlled replacement of the 
material by regenerated tissue. The chemical composition, structure and surface 
properties, as well as the biomechanical properties of the scaffold are crucial for its 
interaction with cells and tissues and subsequently, for tissue regeneration.      
 
 
1.6.1. Biocompatibility 
 
 
Synthetic polymers implanted in the body may be recognized as foreign by 
the immune system of the host. In the first step, this process includes the adsorption 
of bioactive proteins, such as complement, fibronectin, fibrinogen, or plasma 
proteins which then act as a matrix for the interaction with the cells of the immune 
system. The adsorption starts immediately after an implantation and after a few hours 
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the material is coated with a chaotic layer of denatured or partially denatured 
proteins. The immobilization is influenced by the chemical compostion of the 
material, the presentation, quantity and conformation of funtional groups. An acute 
inflammatory reaction is reflected by fagocytic cell accumulation. The macrophages 
that adhere on the surface of the implant are derived mostly from circulating 
monocytes. Monocyte activation is mediated by several factors including adhesive 
contacts, and leads to macrophage formation, and activation of immediate-early 
response genes, such as genes for IL-1 and IL-8, tumor necrosis factor, and 
transcription-associated proteins, such as c-fos or c-jun (Kao et al. 1995, Tang and 
Eaton 1995, Smetana et al. 1997, Hu et al. 2001).       
 Monocyte adhesion and spreading depend on the chemical composition of the 
scaffold. Smetana et al. (1993, 1997) demonstrated that dimethylamino groups in 
dimethylaminoethyl metacrylate copolymer with poly(2-hydroxyethyl methacrylate) 
lead to increased macrophage spraeding and subsequent macrophage fusion into 
foreign-body giant multinucleate cells. In contrast, the expression of carbohydrate 
binding sites for galectins, β-N-acetylgalactosamine, α-mannoside, specific lectin for 
heparin, and lymphokine-macrophage migration inhibitory factor was not dependent 
on the chemical structure of the polymers (Smetana et al. 1997). 
Chronic inflammatory reactions are accompanied by the accumulation of 
macrophages and/or foreign-body giant cells. The biomaterial-associated phagocytes 
are responsible for biomaterial-mediated adverse responses, including inflammation 
surrounding many types of implants, implant degradation and stress-cracking, tissue 
fibrosis surrounding mammary prosthesis, joint and other types of implants, and 
device-centered infection (Hu et al. 2001).   
 Both collagen and HA are the major components of ECM and tissues and 
they should not be immunogenic, provided they have not been contaminated during 
processing and there are no cross-species issues. Similarly, natural derived chitosan 
has been shown to be nonimmunogenic if it is purified, although it has a chemotactic 
effect on neutrophils (Drury and Mooney 2003). 
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1.6.2. Porosity 
 
 
Porosity is defined as the percentage of void space in a solid, and it is a 
morphological property independent of material (Karageorgiou and Kaplan 2005). In 
bone formation, pores are necessary for migration and proliferation of osteoblasts, 
mesenchymal stem cells, and vascularization, while large pores improve bone 
ingrowth. Both chondrocyte migration and proliferation are increased in scaffolds 
with a high porosity. Interconnected pores provide cells with nutrition, growth 
factors and cytokine supplementation. In addition, porous surface (higher roughness) 
allows mechanical interlocking between the implant and the surrounding bone tissue 
which provides better mechanical stability of the implant and leads to better 
osseointegration (D'Lima et al. 1998, Karageorgiou and Kaplan 2005).   
The specific surface area, which is the surface area per unit volume, was 
found to correlate linearly with cell atachment and viability. On the other hand,  
avarage pore size above 100 μm caused decreased attachment of mouse clonal 
osteogenic cells (O'Brien et al. 2005).    
The pore scaffolds can be prepared by various techniques, including salt 
leaching, molding, porogen melting, melt blowing, sintering, gas foaming, porogen 
dissolving, emulsion polymerization, and electrospinning (Fig.4). The pore size in 
scaffolds varies from 2 to 800 μm, and can be tailored for different applications 
(Karageorgiou and Kaplan 2005).   
   
 
 
 
 
 
 
 
Fig. 4. Different structure and porosity of gelatine foam (left) and nanofibre PLGA 
scaffold (right). 
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1.6.3. Surface properties  
 
 
The surface characteristics determine the adsorption of biological materials. 
The nature of conditioning materials as well as their orientation on the surface 
directly affect cell recruitment, attachment, spreading, proliferation, and 
differentiation (Fig.5). Thus, chemotactic factors are necessary for cell recruitment, 
specific binding proteins on the surface allow cell attachment, and growth factors and 
cytokines are essential for cell proliferation and differentiation (Boyan et al. 1996). 
Cells interact with the surface material through integrin receptors that 
assemble into focal adhesion plaques. The type and geometry of focal adhesions 
determine the cell shape and changes in the cell shape alter the transduction of 
extracellular signals to the cell via integrin receptors and thus influence their 
phenotypic expression (Enomoto et al. 1993, Aplin et al. 1998). Chondrocytes 
cultured in a monolayer become flattened, with the morphology of fibroblast-like 
cells, and dedifferentiate. However, when they are embedded in a three-dimensional 
scaffold, they become round and redifferentiation occurs (Benya and Shaffer 1982).  
 
 
 
 
 
 
 
 
Fig. 5. Chondrocyte growth on microstructured surface of gelatin foam (left) and 
nanostructured surface of PLGA nanofibre scaffold (right) 14 days after seeding 
(confocal microscope, propidium iodide staining, obj. × 10). 
 
Bone cells, epithelial cells, and fibroblasts are sensitive to the gross 
morphology of the material. The optimized pore diameter in the range of 200-400 μm 
is known to enhance osteoblast attachment, proliferation and migration. This 
curvature may provide optimum compression and tension on cell´s 
mechanoreceptors.  
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Chondrocyte and osteoblast attachment, proliferation and extracellular matrix 
synthesis is influenced by surface roughness. Immature osteoblast-like MG63 cells 
showed decreased cell number, [3H]-thymidine incorporation and alkaline specific 
activity, when grown on rough cpTi surfaces. Resting chondrocytes showed the same 
results as MG63 cells, while growth zone chondrocytes, which are more mature than 
resting chondrocytes, displayed different results. This indicates that the cell response 
to the surface roughness is influenced by the maturation state of the cells. In another 
experiment, different spreading of MSCs on smooth and rough surfaces was 
observed (Boyan et al. 1996). Topography of the substratum influences the cell 
shape and movement. The cell alignment on multiple grooved substrate increased 
with the groove depth  (Clark et al. 1990).   
Nanostructured and microstructured surfaces of PLGA/titanium and PLGA 
improved chondrocyte and osteoblast adhesion in comparison with conventional 
polymer films but the nanostructure of the surface was more effective (Kay et al. 
2002). 
The surface energy is defined by its general charge density and the net polarity of the 
charge. Thus, a surface with a net positive or negative charge may be hydrophilic in 
character, and a surface with neutral charge may be more hydrophobic. The net effect 
of the surface charge creates a local environment with a specific surface tension, 
surface free energy, and energy of adhesion. The biological response is determined 
by the relative strength of the serum–surface interaction. This interaction can be 
defined as interfacial free energy that is the most important for the process of cell 
adhesion (Boyan et al. 1996). 
 
1.6.4. Biomechanical properties of scaffolds  
 
After the implantation of the scaffold into the weight-bearing part of the knee 
joint, the scaffold is subjected to a cyclic loading. Chondrocytes embedded in the 
scaffold are able to withstand such high forces only if the scaffold possesses 
adequate biomechanical properties, and if it is able to transmit the loading in an 
appropriate manner to the cells and tissues. Therefore, for optimum scaffold 
characterization, it is necessary to cover the whole extent of physiologically possible 
strains, and to characterize the basic material parameters, such as dynamic stress-
strain relationship, Young’s modulus strain dependence, and energy losses. 
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From the mechanical point of view the cartilage can be regarded as a so-
called poroelastic material, hence a biphasic model has been developed to describe 
its basic mechanical properties. The mechanical parameters, such as stiffness or 
Young’s modulus and viscoelastic characteristics, are highly strain-rate-dependent. 
In order to better understand the real dynamic behavior of the material, several 
attempts have been made both to measure and to simulate the impact loading stress 
state (Ateshian et al. 1997, Mow and Guo 2002).  
Physical properties of the scaffolds are influenced by a gel formation 
mechanism and dynamics, mechanical characteristics and degradation behavior. The 
mechanical properties of hydrogels are affected by polymer concentration and 
characteristics, by cross-linking agent and its characteristics (e.g.concentration, type, 
size of molecules), gelling conditions, such as temperature and pH, and by swelling 
and degradation (Drury and Mooney 2003). Higher polymer concentration increases 
the compression modulus and the equilibrium shear modulus (LeRoux et al. 1999). 
The gelling conditions must be in the range of physiological conditions so that the 
cells survive.  
Hydrogel swelling and degradation lead to weakening of the gel. The 
weakening can be reduced if cells produce extracellular matrix or if the surrounding 
tissue grows into the scaffold. The desired degradation kinetics may vary due to 
specific scaffold application. The optimum scaffold degradation copies the rate of the 
new tissue formation. On the other hand, the controlled release of bioactive 
substances needs controlled degradation rate. The hydrogels degrade by hydrolysis, 
enzymic cleavage, and dissolution. The natural derived polymers, such as chitosan, 
collagen and hyaluronic acid, are degraded enzymically, and the degradation rate 
depends on the number of cleavage sites in the polymer and enzyme concentration in 
the scaffold environment. On the other hand, synthetic polymers are usually 
degraded by hydrolysis of ester linkages; the hydrolysis is constant in vitro and in 
vivo (Drury and Mooney 2003). 
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1.6.5. Natural and synthetic hydrogel scaffolds used in cartilage regeneration  
 
Natural derived scaffolds  
Hydrogels from biopolymers permit three-dimensional immobilization of the 
cells and provide the proper environment that supports chondrocyte and MSC 
differentiation (Benya and Shaffer 1982, Brittberg et al. 1997, Radice et al. 2000, 
Drury and Mooney 2003, Ng et al. 2005). Due to their biodegradability and 
biocompatibility they are widely used as tissue substitutes in many applications, such 
as cartilage, vascular, skin, liver, intestine, and urological tissue repair (Vacanti et al. 
1998). However, their limitations include batch-to-batch variation upon isolation 
from biological tissues as well as restricted possibility to design scaffolds with 
specific biomechanical properties. 
Hydrogels mimic the natural highly hydrated cartilage that contains above 90 
% of water (Buckwalter and Mankin 1998a). The high water content facilitates 
transport of nutrients. They are prepared from naturally derived biopolymers, such as 
fibrin, collagen, chitosan, agarose, alginate, and hyaluronic acid derivatives.  
Fibrinogen and fibrin play an important role in blood clotting, fibrinolysis, 
cellular and matrix interactions, inflammation, wound healing, and neoplasia. The 
fibrin network is formed from fibrils that undergo further lateral associations and 
form branches by two types of branching. The tetramolecular or bilateral branch 
consisting of large fiber bundles and more condensed bilateral brand structure 
confers strength and rigidity to the network fibers. Trimolecular or equilateral branch 
is formed by coalescence of three fibrin molecules that connect three double-stranded 
fibrils of equal width. The architecture is influenced by various factors, such as 
thrombin concentration, and the availibality of intermediate fibrin units (Mosesson et 
al. 2001)  .   
At the site of injury, the fibrin clot serves as a provisional scaffold for the 
recruitment of fibroblasts, endothelial cells and monocytes. To recognize the fibrin 
clot, the migrating cells use integrin receptors for fibrin, fibronectin and vitronectin 
(Clark 2001). The activated macrophages play an important role in fibrin degradation 
by production of proteolytic enzymes, such as plasmin, plasminogen activators, 
collagenase and elastase. Moreover, the degradation is influenced by the presence of 
protease inhibitors, and fibrin fragments. Fibrin is gradually replaced by collagen and 
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other ECM components produced by cells (Bense and Woodhouse 1999, Clark 
2001).  
 
Synthetic scaffold 
In situ gel-forming hydrogels, such as modified polyethylene oxide (PEO), 
have been succesfully used in chondrocyte encapsulating. Some limitations, 
however, exist with respect to controlling the mechanics and uniformity of the gel. 
Synthetic polymers, e.g. polyvinyl alcohol and polyethylene glycol have been studied 
(Bryant and Anseth 2001, Stammen et al. 2001, Bryant and Anseth 2002, Kobayashi 
et al. 2003). Cross-linked hydrogels (Bryant and Anseth 2002), or porous scaffolds 
prepared from hydrogels by cross-linking and/or by freeze-drying exhibit increased 
stiffness and reduced degradation velocity (Chang et al. 2003). The chondrocyte 
viability and extracellular matrix synthesis in the photocross-linked PEO scaffolds 
was not affected by the high stiffness of the scaffold (Bryant and Anseth 2001). They 
allow preparation of scaffolds of variable composition, biological, and biomechanical 
properties, especially when they are combined with other hydrogels, woven or non-
woven scaffolds, and other polymer scaffolds (Minoura et al. 1998, Caterson et al. 
2001, Park et al. 2004).  
 Synthetic polyesters, such as PLLA, PGA and copolymer PLGA, have been 
intensively studied; they have been already used in clinical practice as sutures and 
medical devices. Porous synthetic scaffolds demonstrated a higher stiffness 
compared with hydrogels but also an increased fragility and low elasticity. Therefore, 
they are not suitable for cartilage regeneration. Conversely, the textile woven 
scaffolds with improved elastic properties can be utilized in tissue engineering.  
 
 
1.6.6. Hydrogel applications 
 
 
In tissue engineering, hydrogels are applied as space-filling agents which are 
used in many applications including bulking, adhesion prevention, or bioadhesives, 
and biological glue for soft tissues. The scaffolds used as space-filling agents should 
maintain the desired volume and structural integrity for the desired time. Many 
scaffolds including alginate, chitosan, and collagens have the potential for use as a 
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bulking agent. They have been used in the treatment of urinary incontinence, 
vesicoureteral reflux, and for both plastic and reconstructive surgery. The 
antiadhesive polymer PEG is used as a prevention of post-operative adhesion. 
Conversely, adhesive polymers, such as fibrin and chitosan, can seal soft tissues and 
allow air and body fluid leakage from the wound, which improves wound dressing 
(Wang et al. 1995). Hydrogels can serve as delivery vehicles for bioactive 
substances, such as TGF-β, vascular endothelial growth factor and bFGF, which 
promote cell differentiation or angiogenesis (Park, H. et al. 2005). Moreover, 
hydrogels supply the wound with antibiotics (Park et al. 2004). Controlled drug 
delivery is in demand in many applications, including wound healing and tissue 
regeneration. The incorporated bioactive molecules are released by diffusion, 
mechanical stimulation, and degradation (Ruel-Gariepy et al. 2000, Saito et al. 
2001). Finally, hydrogel scaffolds seeded with transplanted cells are able to 
regenerate the majority of tissues including skin, cartilage, bone, muscle, fat, liver, 
and neurons (Drury and Mooney 2003). To improve cell adhesion, cell non-adhesive 
synthetic hydrogel scaffolds can be modified with cell adhesion peptides such as 
RGDS. In addition, the incorporation of degradation sites increased the proliferation 
of vascular smooth muscle cells and their penetration into the scaffold (Schmedlen et 
al. 2002).  
 
 
1.6.7. Future trends in cartilage tissue engineering 
 
 
The first generation of cartilage regeneration used an autologous chondrocyte 
implantation with a periosteal flap. The second one was based on the implantation of 
three-dimensional scaffolds or osteochondral transplants, and the delivery of 
bioactive substances.      
The future development of the third generation of scaffolds involves the 
cellular and molecular basis of tissue regeneration. The gene-activating biomaterials 
should be tailored for specific patients and disease states. The construct seeded with 
the patient`s own cells should provide the optimum treatment. Another approach 
includes gene-activating biomaterials that prevent further denegenerative processes 
in the tissue, or even improve a tissue function (Hench and Polak 2002).  
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1.7. Objectives of the study 
 
My experiments were focused on cartilage defect regeneration. They included 
the following stages: 
 
1. Improvement of healing of osteochondral defects using oral 
supplementation of GAGs and antioxidants. 
2. Development of three-dimensional biocompatible and biodegradable 
artificial scaffold for articular cartilage regeneration, which possesses appropriate 
biomechanical properties. 
3. Evaluation of osteochondral defect regeneration using a composite scaffold 
seeded with autologous chondrocytes. 
 4. Evaluation of physeal defect regeneration using a composite scaffold 
seeded with autologous mesenchymal stem cells. 
 
This PhD Thesis is composed of four attached publications where applied 
methods and experimental details can be found. 
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2. Results 
 
 
2.1. Peroral supplementation of GAGs and antioxidants 
 
Histological analysis showed a higher organization level of the cartilage-like 
repair tissue in the healed osteochondral defect in the GAG group in comparison with 
the placebo group. The amount of the sulfated GAG in the osteochondral defects of 
the GAG group was significantly higher (p < 0.03) than in the control group (Table 
1). In both groups the total GAG content in the cartilage of the operated knee joint 
was also significantly higher (p < 0.05) than that in the non-operated knee joint. 
Histological analysis showed a higher organization level of the cartilage-like 
repair tissue in the healed osteochondral defect in the GAG group in comparison with 
the placebo group. 
The amount of the sulfated GAG in the osteochondral defects of the GAG 
group was significantly higher than in the control group (Table 1). In both groups the 
total GAG content in the cartilage of the operated knee joint was also significantly 
higher (p < 0.05) than that in the non-operated knee joint. 
 
 
  Defect Cartilage - Cartilage - 
  [%] operated knee [%] 
non-operated knee 
[%] 
GAG group 8.8 ± 1.1 * 9.6 ± 1.7  + 5.9 ± 1.7 
Control 6.0 ± 1.6  6.8 ±  1.5 + 3.6 ± 1.6 
 
Table 1. The amount of sulfated GAG as share of the total weight of the regenerated tissue in 
the osteochondral lesions (mean ± SEM, *  p< 0,001, +p < 0,05)  
 
The amount of synovial fluid was increased in the placebo group while the 
viscosity of the synovial fluid was significantly enhanced in the GAG group (90.0 ± 
2.9 vs. 69.4 ± 4.9 poise,  p < 0.001). (Fig. 1) 
 
2.2. Development of composite scaffold for cartilage regeneration 
 
We developed the shock dynamic method for biomechanical characterization 
of cartilage. With regard to the distinct poroelastic and viscoelastic material 
properties of cartilages, blunt impact response evaluation seems to be the most 
promising method to obtain comprehensive mechanical data. Simple laboratory 
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realization, repeatability and sufficient accuracy are the main features of this 
approach. 
The reaction of poroelastic material to static, dynamic and impact loading 
differs substantially. An example of cartilage biomechanical characteristic 
comparison obtained by both the proposed impact dynamic method and static loading 
test using strain rates of 5 mm min–1 and 10 mm min–1 is shown in Fig. 1. 
 
Fig. 1. Comparison of single pig joint cartilage sample stress-strain curves for static (strain 
rate 5 mm/min and 10 mm/min) and impact (shock test) loading. 
 
The nonlinear shape of each loading curve results predominantly from large 
strains of unconfined compression, as the interstitial fluid flow within the tissue is 
sufficient for its escape from the material structure at low loading rate. 
Healthy joint cartilage response consists of a nearly linear part characterizing 
elastic matrix, followed by steep nonlinear part caused mainly by viscous fluid. In 
damaged cartilage, the diagram changes usually occur in favor of linearity due to 
damaged porous structure. 
Four different chondrocyte-seeded hyaluronan-type I collagen-fibrin 
composite scaffolds displayed excellent viability of chondrocytes (84 % to 97 %) 
after a 7- and 14-day cultivation.  The stiffness of the tested composite matrix 
(scaffold 1) was significantly higher than that of the fibrin gel (scaffold 4) but also 
better than that of scaffold 2, or 3 (Fig. 2). 
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Fig. 2. Loading diagrams of different composite scaffolds in comparison with native rabbit 
cartilage. Four different composite scaffolds (six pieces of each) were prepared, using 3 × 
104 cells per scaffold. Hyaluronan/collagen volume ratio was 12.5/18.8 (sample 1), 16.3/13.6 
(sample 2), 8.8/24.2 (sample 3). Sample 4 was prepared from Tissucol and Thrombin 
solutions without hyaluronan and collagen. Fibrin scaffold was recently used in clinical 
application (Handl et al. 2006).  
 
2.3. Regeneration of osteochondral defects in miniature pigs  
 
The composite scaffold 1 with the best biomechanical properties was 
subsequently implanted in osteochondral defects in miniature pigs.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Histology of osteochondral defects A of the chondrocyte-seeded scaffold group (A, C) 
and non-seeded group (B, D) after 24 weeks using Alcian blue staining and PAS reaction at 
pH 2.5 (A, B), and immunohistochemical staining using monoclonal antibody against type II 
collagen (C, D). Magnification × 100 (B), × 40 (A, C, D).   
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Fig. 4. Histology of osteochondral defects of the control group after 24 weeks using HE 
staining (A), Alcian blue staining and PAS reaction at pH 2.5 (B, D), and 
immunohistochemical staining using monoclonal antibody against type II collagen (C) which 
showed chaotic sparse fibrous tissue with negative both GAG and type II collagen staining 
(A,B,C). Magnification × 40 (A, C, D), × 100 (B). 
 
In the A defects of chondrocyte-seeded scaffold group, hyaline cartilage and 
fibrocartilage was formed, containing type II collagen, acidic and neutral 
glycosaminoglycans while the non-seeded scaffold group was predominantly filled 
with fibrocartilage (Fig. 3). Defects in the control group were predominantly filled 
with fibrous tissue (Fig. 4). 
Histomorphometric analysis of photomicrographs revealed a significantly 
higher amount of hyaline cartilage in the cell-seeded scaffold group in A defects than 
in other groups. Both scaffold groups in A defects showed significantly less fibrous 
tissue than cell-seeded defects B and the control group.  
 
2.4. Regeneration of physeal defects in rabbits  
 
Prophylactic transplantation of autogenous mesenchymal stem cells to 
iatrogenically damaged distal growth plate of rabbit femur prevented bone bridge 
formation and resulted in healing of the physeal defect with hyaline cartilage (Fig. 5). 
Immunofluorescence examination showed that the chondrocytes newly formed in the 
growth zone are the result of implanted MSCs differentiation. 
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Fig.5. Histological examination of the distal femoral physis in 
rabbits after autogenous MSCs transplantation (HE stain, 
magnification × 40), arrows point to isolated cartilage islets in 
the defect of growth cartilage. 
 
 
 
 
Fig. 6 Valgus deformity of the distal section of the left (L) femur 
(without transplantation of MSCs into the growth zone defect) and 
the right (P) femur in rabbit. Measured from X-ray photographs of 
femurs in CC projection after euthanasia (4 months after 
transplantation of MSCs). 
 
 
 
Femur growth in traumatized physis was maintained even after 
transplantation of autogenous MSCs (Fig. 6). As compared with the opposite femur 
(with physeal defect but without transplanted MSCs), the bone showed no significant 
shortening or valgus deformity (p = 0.018).  
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3. Discussion 
 
 
3.1. Regeneration of cartilage using non-invasive methods 
 
 
Proteoglycans form a viscoelastic layer which lubricates and protects the 
cartilage surface (Buckwalter and Mankin 1998a). Changes of both structure and 
chemical composition of glycosaminoglycans observed in OA result in reduced 
biomechanical properties of the cartilage (O'Driscoll 1998). Proteoglycans, as well as 
other substances, have exhibited a potential chondroprotective effect in the 
conservative treatment of OA (McAlindon et al. 2000, Reginster et al. 2001, 
Raynauld et al. 2002, Towheed 2002). In clinical studies, the peroral 
supplementation of GAG could improve clinical symptoms and radiological 
parameters in patients with cartilage damage or OA (Reginster et al. 2001, Pavelka et 
al. 2002). However, no link between peroral supplementation of these drugs and 
structural changes in cartilage was demonstrated. 
Peroral supplementation of a mixture of GAGs, enzymically extracted from 
fish cartilage to a size between 1 500 and 2 500 Da, and antioxidants (vitamin E and 
selenium) used in our study improved healing of osteochondral defects in many 
respects. Regenerated fibrocartilage displayed a significantly higher amount of 
sulfated GAGs. However, the surrounding tissue of both tested and control groups 
contained a significantly higher amount of total GAGs, which was probably caused 
by activation of chondrocytes by cytokines released as a consequence of the 
operation. In addition, the viscosity of the synovial fluid was increased in the 
operated joint. In accordance with a previous observation, peroral supplementation of 
GAGs reduced the effusion in the GAG-treated joints. This may be explained by the 
antiinflammatory potential of GAGs (McAlindon et al. 2000).  
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3.2. Articular cartilage regeneration using autologous chondrocytes 
 
 
The operative treatment of cartilage lesions and OA depends on the degree of 
cartilage damage, and the age of the patient. Although the old patient can profit from 
joint replacement, the limited life of the prosthesis does not allow to use this 
technique in younger patients (Sharkey et al. 2002). Standard surgical techniques, 
such as debridement, soft-tissue grafts or penetration of the subchondral bone can 
improve joint function but they are not able to restore normal articular cartilage 
(Buckwalter and Lohmander 1994, Levy et al. 1996, Buckwalter and Mankin 
1998b). Therefore, the cell-based therapy of chondral and osteochondral lesions was 
developed. 
In our study on miniature pigs we used autologous chondrocytes from non-
weight-bearing cartilage. Autologous chondrocytes have been used in ACI and 
MACI techniques with good results (Brittberg et al. 1994, Minas 2001, Marlovits et 
al. 2006). However, multiplication of chondrocytes in older donors or patients with 
OA may be difficult because their chondrocytes were reported to have a low 
proliferative capacity and exhibited the signs of degeneration.  
The formulation of the ideal scaffold should respect chemical, biological and 
biomechanical properties of the cartilage. This difficult task has not been 
accomplished yet. There may be many causes for this: cell proliferation is limited by 
low diffusion of the nutrients through the scaffold; the nutrition depends on the 
scaffold structure, thickness, porosity, pore size and interconnectivity, and the 
conditions of cultivation.  
Fibrin clot plays an important role in wound healing. It serves as  
a provisional matrix for migration of many cell types, such as monocytes, fibroblasts 
and endothelial cells into the matrix. Fibrin clot  serves as a reservoir of growth 
factors that regulate cell functions (Clark 2001). In vitro, the advantage of using 
fibrin and other hydrogels is the homogeneous cell seeding during scaffold 
preparation. The fibrin gels produced from patients promoted ECM matrix synthesis 
as a consequence of releasing TGF-β and PDGF; the newly synthesized matrix is 
accumulated in the original matrix (Jockenhoevel et al. 2001). Similarly, the 
homologous fibrin gel prepared from rabbit and human blood supported cell 
ingrowth but, when fibrin gel from commercially available Tisseel® was used, no cell 
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ingrowth was observed (Brittberg et al. 1997). Another advantage is that the 
fibrinogen/thrombin concentration was able to control gel rigidity that was critical 
for the viability of human MSCs (Bensaid et al. 2003). Moreover, fibrin gel can be 
prepared in situ in a desired shape, and it serves as glue which does not require 
further suturing. 
The disadvantages of fibrin include its inapropriate mechanical properties, 
such as low viscoelasticity and stiffness, rather quick shrinkage and degradation of 
the gel (Jockenhoevel et al. 2001, Bensaid et al. 2003). However, the shrinkage can 
be reduced by chemical or mechanical fixation. The mechanical fixation of the gel 
using poly-L-lysine induced collagen synthesis and improved the mechanical 
properties of the fibrin scaffold (Jockenhoevel et al. 2001). The other means of 
improving the mechanical properties include preparation of the composite scaffold. 
For example, the viscoelastic behavior of our composite fibrin scaffold was 
positively influenced by high-molar-mass hyaluronic acid, and the stiffness was 
increased by the content of collagen.  
The desired scaffold should possess mechanical properties similar to native 
cartilage. Small diameter and thickness, low material stiffness as well as highly 
nonlinear and strain-rate-dependent properties of the scaffolds tested should be taken 
into account for using the appropriate testing method. Cartilage mechanical 
properties have already been evaluated by both static and dynamic tests (Repo and 
Finlay 1977, Kerin et al. 1998, LeRoux et al. 1999, Duda et al. 2000). In a static test, 
the sample is continuously being adapted to applied stress, while in the dynamic test, 
the strain rate is too fast, and adaptation to applied stress is not possible. Under 
physiological conditions, an impact loading is applied on the joint. Therefore, we 
developed a novel shock dynamic method.  
The poroelasticity and viscoelasticity are complex nonlinear properties that 
cannot be described by a simple characteristic value, e.g. Young's modulus and 
Poisson's ratio. However, loading diagrams, such as stress-strain or  
force-strain diagrams appear to be suitable for characterization of poro- and visco-
elastic properites of the cartilage or our scaffolds. The nearly linear part of the stress-
strain diagram corresponds to the elastic properties of the matrix, and the following 
nonlinear part corresponds to viscous fluid (Mow and Guo 2002). However, the 
nonlinear shape of the dynamic loading curve results predominantly from large 
strains of unconfined compression because the interstitial fluid within the tissue is 
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not able to escape at these high loading rates. The loading diagram of pure fibrin glue 
exhibited a more linear curve compared with both pig cartilage and woven PGA 
scaffold due to the different structure of fibrin and the lack of viscous fluid inside the 
fibrin gel. The loading diagrams of both native pig cartilage and the composite 
scaffold had a similar nonlinear course that indicated outstanding viscoelastic 
properties of the tested materials as well as dynamic response resembling the 
properties of native cartilage.  
It has been reported that pure fibrin sealant Tisseel® implanted into 
osteochondral defects in rabbits did not allow any cell migration into the gel after 
eight days. After four months, only incomplete irregular fibrous or fibrocartilaginous 
tissue formation were observed. This finding is in agreement with in vitro tests 
(Brittberg et al. 1997). The implanted fibrin sealant probably created a strong 
hemostatic barrier that prevented cell migration from the endogenous fibrin clot 
formed in the base of the osteochondral defect. The commercially available products 
Tisseel® and Tissucol® contain a twenty-fold higher concentration of fibrinogen and  
a fifty-fold higher concentration of factor XIII, a fibrin cross-linking factor, 
compared to plasma. This probably led to the formation of fibrin mesh of a structure 
differing from normal fibrin clot (Brittberg et al. 1997). 
Heterologous chondrocyte-seeded fibrin implanted into the ostechochondral 
defect in the weight-bearing zone was reported to repair the defect to a limited 
extent. After 13, 26, and 52 weeks post implantation, the fibrocartilage was formed 
in both chondrocyte-seeeded and non-treated control groups. Moreover, in the 
chondrocyte-seeded group,  many dead cells were observed in the central part of the 
defects. This was accompanied by the migration of leukocyte-like inflammatory cells 
into the progressively degraded fibrin (van Susante et al. 1999).  
Composite scaffolds prepared from two or more biopolymers are supposed to 
utilize the benefits of both components. Biocompatible, biodegradable polymers, 
such as collagen, alginate, fibrin or hyaluronic acid, support cell attachment, 
proliferation or control cell differentiation (Chang et al. 2003, Park et al. 2004). 
Hyaluronic acid as a natural component of the cartilage plays the most important role 
in chondrocyte differentiation (Park, S. H. et al. 2005, Yoo, H. S. et al. 2005).  
Our composite scaffold, composed of hyaluronan, type I collagen and fibrin, 
led to hyaline and fibrocartilaginous cartilage formation in the autologous 
chondrocyte-seeded group. We suppose that the superior biomechanical properties of 
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our scaffold were essential to resist the dynamic loading during movement. This 
prevented the damage of the cells inside the scaffold, supported their survival, 
proliferation and cartilage formation, and improved healing compared to pure fibrin 
scaffolds used by the authors mentioned above (Brittberg et al. 1997, van Susante et 
al. 1999). The biomechanical properties of the artificial matrices can be improved by 
synthetic components, e.g. PLGA copolymer with well defined structure, physical 
and  chemical properties (Chen et al. 2003). 
 
 
 3.3. Physeal cartilage regeneration using autologous mesenchymal stem cells  
 
 
The injuries of long bones are very often associated with damage of physis, 
such as distal physis of ulna or distal physis of femur. Physes do not heal 
spontaneously and may result in the formation of a bony bridge at the site of injury. 
If the bony bridge takes 7 to 9 % of the physis area, a shortening and/or deformity of 
the bone is observed (Gál et al. 2002). Clinical therapy of physeal injuries has been 
targeted as therapy of bone shortnening and deformity (Lee et al. 1993). In our study 
we used a distal femoral physis defect as a model, because the distal femoral physis 
is critical for longitudinal growth of the femur. The second reason was that the 
injuries of the distal femur were more frequent than in the proximal femur (Maretta 
and Schrader 1983, Mann and Rajmaira 1990). 
Recently, a new approach to the prevention of bony bridge formation has 
been found. It includes an implantation of autologous chondrocytes, MSCs or 
perichondrial cells either in suspension or in a three-dimensional scaffold.  
Suspension of chondrocytes injected into a partial physeal defect of proximal 
epiphyseal plate of tibia (50 % of physis) leaked out from the defect and growth 
arrest was observed. On the other hand, chondrocytes embedded in agarose gel 
prevented the bony bridge formation and growth arrest. Moreover, they were able to 
regenerate physeal cartilage even if the bony bridge had been formed before 
transplantation (Lee et al. 1998). Gál et al. (2002) reported that articular 
chondrocyte-seeded fibrin graft prevented the formation of bony bridge. In addition, 
perichondrium-derived chondrocytes embedded in alginate-fibrin beads were able to 
partially restore the growth plate (Yoo, W. J. et al. 2005).  
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 In our study MSCs were used for the repair of physeal cartilage. Adult MSCs 
can differentiate into the chondrocytes and thus have a therapeutical potential for the 
cartilage and growth plate repair. They can be obtained from bone marrow without 
destroying the healthy cartilage. In addition, the ethical, moral and legal issues 
associated with the use of embryonic stem cells are avoided. The chondrogenic 
stimulation of the MSCs and their seeding on the appropriate scaffold are the key 
factors in cartilage regeneration. Ahn et al. (2004) reported that after the embedding 
MSCs in different gelatin scaffolds, significant physis repair was observed only in 
the group of Gelfoam scaffold, probably due to the leakage of the cells from the 
scaffolds made from 5 and 10 % gelatin.  
In our study on rabbits, MSCs were embedded into composite hyaluronan-
type I collagen-fibrin scaffold and implanted into the distal growth plate of the femur 
by arthroscopic instruments without destroying the scaffold. After four months, the 
structure and morphology of regenerated physis resembled both hyaline cartilage and 
fibrocartilage. Morevoer, the regenerated physeal cartilage prevented the bony bridge 
formation and valgus deformation of the femur. Before the implantation, vimentin in 
MSCs was stained with a lipophilic fluorescent dye. The staining was present in 
physeal chondrocyte-like cells even 4 months after the implantation. The use of 
MSCs in the therapy of physis trauma is promising for young patients, because it 
prevents the closure of long bone growth plates causing both bone shorterning and 
deformities.  
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.4.  Conclusions 
 
Peroral supplementation of a mixture of both GAGs and radical scavengers 
(vitamin E and selenium) resulted in higher amount of sulfated GAGs in the repaired 
tissue of the osteochondral defect of rabbit compared to the contralateral joint. This 
was accompanied by the increased viscosity of the synovial fluid in the treated joint. 
The combination of GAGs and radical scavengers can be used as supporting therapy 
in the treatment of osteochondral defects. 
 The viscoelastic properties of the cartilage cannot be characterized by a 
simple value of Young´s modulus or Poisson´s ratio. We introduced the novel 
dynamic shock method to characterize highly nonlinear and strain-rate-dependent 
properties of cartilage. The advantages of the method include measurement of 
samples of small size and thickness as well as fast and reproducible measurement of 
complex nonlinear characteristics of the sample during a simple measurement. This 
method was used to characterize newly developed scaffolds. The biomechanical 
properties of fibrin gel were far from the native cartilage. We have developed 
composite type I collagen-hyaluronan-fibrin scaffold which showed a similar course 
of loading diagram as native cartilage. This indicates viscoelastic properties similar 
to those of native cartilage. This scaffold has been subsequently used in tests in vivo.   
 Chondrocytes embedded in a three-dimensional hydrogel scaffold maintain 
their differentiated phenotype or even re-differentiate. Autologous chondrocyte-
seeded fibrin scaffold implanted into osteochondral defects of goat resulted in 
incomplete regeneration of the defect. The autologous chondrocyte-seeded type I 
collagen-hyaluronan-fibrin scaffold, characterized by improved biomechanical 
properties, implanted into the osteochondral defects in miniature pigs, resulted in 
improved healing of the defects and hyaline cartilage or fibrocartilage formation 
while the non-seeded composite scaffold led predominantly to fibrocartilage 
formation. Moreover, no shrinkage was observed probably due to better viscous 
properties of the sample.  
MSCs isolated from bone marrow have shown the potential to differentiate 
into many cell types including cartilage and bone under specific culture conditions. 
In our study, autologous MSC-seeded composite type I collagen-hyaluronan-fibrin 
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scaffold implanted into iatrogenic physeal defect in lateral portion of distal growth 
plate prevented bone bridge formation and resulted in healing of physeal defect with 
both hyaline cartilage and fibrocartilage. This was not accompanied by any 
significant valgus deformity and shortening of the bone. The therapy of physeal 
defects using MSC-seeded composite scaffold can avoid surgical intervention in the 
treatment of consequences of physeal closure, such as bone deformities and 
shortening of bone. 
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